Literature DB >> 11715041

Chromosomal microdeletions: dissecting del22q11 syndrome.

E A Lindsay1.   

Abstract

Identifying the genes that underlie the pathogenesis of chromosome deletion and duplication syndromes is a challenge because the affected chromosomal segment can contain many genes. The identification of genes that are relevant to these disorders often requires the analysis of individuals that carry rare, small deletions, translocations or single-gene mutations. Research into the chromosome 22 deletion (del22q11) syndrome, which encompasses DiGeorge and velocardiofacial syndrome, has taken a different path in recent years, using mouse models to circumvent the paucity of informative human material. These mouse models have provided new insights into the pathogenesis of del22q11 syndrome and have established strategies for research into chromosomal-deletion and -duplication syndromes.

Entities:  

Mesh:

Year:  2001        PMID: 11715041     DOI: 10.1038/35098574

Source DB:  PubMed          Journal:  Nat Rev Genet        ISSN: 1471-0056            Impact factor:   53.242


  80 in total

Review 1.  Genetic abnormalities of chromosome 22 and the development of psychosis.

Authors:  Nigel M Williams; Michael J Owen
Journal:  Curr Psychiatry Rep       Date:  2004-06       Impact factor: 5.285

Review 2.  How insights from cardiovascular developmental biology have impacted the care of infants and children with congenital heart disease.

Authors:  Alvin J Chin; Jean-Pierre Saint-Jeannet; Cecilia W Lo
Journal:  Mech Dev       Date:  2012-05-26       Impact factor: 1.882

3.  Crkl deficiency disrupts Fgf8 signaling in a mouse model of 22q11 deletion syndromes.

Authors:  Anne M Moon; Deborah L Guris; Ji-heui Seo; Leiming Li; Jennetta Hammond; Amy Talbot; Akira Imamoto
Journal:  Dev Cell       Date:  2006-01       Impact factor: 12.270

4.  Inactivation of TGFbeta signaling in neural crest stem cells leads to multiple defects reminiscent of DiGeorge syndrome.

Authors:  Heiko Wurdak; Lars M Ittner; Karl S Lang; Per Leveen; Ueli Suter; Jan A Fischer; Stefan Karlsson; Walter Born; Lukas Sommer
Journal:  Genes Dev       Date:  2005-03-01       Impact factor: 11.361

5.  Mesodermal expression of Tbx1 is necessary and sufficient for pharyngeal arch and cardiac outflow tract development.

Authors:  Zhen Zhang; Tuong Huynh; Antonio Baldini
Journal:  Development       Date:  2006-08-16       Impact factor: 6.868

6.  Overt cleft palate phenotype and TBX1 genotype correlations in velo-cardio-facial/DiGeorge/22q11.2 deletion syndrome patients.

Authors:  Sean B Herman; Tingwei Guo; Donna M McDonald McGinn; Anna Blonska; Alan L Shanske; Anne S Bassett; Eva W C Chow; Mark Bowser; Molly Sheridan; Frits Beemer; Koen Devriendt; Ann Swillen; Jeroen Breckpot; M Cristina Digilio; Bruno Marino; Bruno Dallapiccola; Courtney Carpenter; Xin Zheng; Jacob Johnson; Jonathan Chung; Anne Marie Higgins; Nicole Philip; Tony Simon; Karlene Coleman; Damian Heine-Suner; Jordi Rosell; Wendy Kates; Marcella Devoto; Elaine Zackai; Tao Wang; Robert Shprintzen; Beverly S Emanuel; Bernice E Morrow
Journal:  Am J Med Genet A       Date:  2012-10-03       Impact factor: 2.802

7.  Tbx1 is regulated by tissue-specific forkhead proteins through a common Sonic hedgehog-responsive enhancer.

Authors:  Hiroyuki Yamagishi; Jun Maeda; Tonghuan Hu; John McAnally; Simon J Conway; Tsutomu Kume; Erik N Meyers; Chihiro Yamagishi; Deepak Srivastava
Journal:  Genes Dev       Date:  2003-01-15       Impact factor: 11.361

8.  Whole-genome detection of disease-associated deletions or excess homozygosity in a case-control study of rheumatoid arthritis.

Authors:  Chih-Chieh Wu; Sanjay Shete; Eun-Ji Jo; Yaji Xu; Emily Y Lu; Wei V Chen; Christopher I Amos
Journal:  Hum Mol Genet       Date:  2012-12-06       Impact factor: 6.150

9.  Comparative gene expression analysis of avian embryonic facial structures reveals new candidates for human craniofacial disorders.

Authors:  S A Brugmann; K E Powder; N M Young; L H Goodnough; S M Hahn; A W James; J A Helms; M Lovett
Journal:  Hum Mol Genet       Date:  2009-12-16       Impact factor: 6.150

10.  Micromanaging Palate Development.

Authors:  David E Clouthier; Josie Gray; Kristin Bruk Artinger
Journal:  Perspect Speech Sci Orofac Disord       Date:  2008-10-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.